Liom raises EUR 13.9 M

Liom (formerly Spiden) is developing a wristband that measures blood glucose non-invasively using Raman spectroscopy. The EUR 13.9 million Series A extension brings the Series A to CHF 38 million and will fund product development ahead of a 2028 launch.

Announced on
Round
Series A
Amount
EUR 13.9 M
Location
Pfäffikon, canton of Schwyz
Sector
Health & medtech

Investors

  • Red Bull Ventures
  • Marc Maurer
  • Melih Odemis
  • Alejo Costa Ribalta

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic